Researchers engaged in drug discovery and development seek strategies for understanding the dynamics of drug-target interactions. Measuring the drug-target residence time—the duration of time that a drug remains bound to its target—can help researchers eliminate poor drug candidates, improve a drug’s efficacy, and expand the therapeutic window.
Download this guide from BellBrook Labs to learn how biochemical assays improve drug-target residence time measurements and drug development workflows.
Top Image Credit:
iStock
Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.
View this Issue
Learn how improving sampling, standardization, and calibration streamlines quality control processes.
In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.
Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating technology options for their laboratories.
- Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global network - Hypothermic preservation technology eliminates costs and inefficiencies of cold-chain logistics to enhance biomedical research and cell therapy development
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Singleron Biotechnologies and Hamilton Bonaduz AG today announced the official launch of Tensor under their strategic partnership.
Zymo Research is proud to introduce the RNome Disruptive Research Grant, that is designed to empower scientists mapping the RNome and advance our overallunderstanding of RNA.
